Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-06 Purchase |
2024-02-06 1:08 pm |
Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer |
5,000 | $0.98175 | $4,909 | 12,859 (Direct) |
View |
| 2022-06-06 Purchase |
2023-02-07 4:53 pm |
Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer |
5,000 | $1.411 | $7,055 | 7,859 (Direct) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:20 pm |
Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer |
1,500 | $20 | $30,000 | 1,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-04 Option Award |
2024-03-06 1:28 pm |
N/A 2034-03-03 |
Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer |
654,000 | $0 | 235,000 (Direct) |
View |
| 2023-02-27 Option Award |
2023-02-28 4:30 pm |
N/A 2033-02-26 |
Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer |
728,270 | $0 | 728,270 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-23 9:18 pm |
N/A 2032-02-17 |
Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer |
630,000 | $0 | 630,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 4:59 pm |
N/A 2031-02-03 |
Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer |
340,000 | $0 | 340,000 (Direct) |
View |
Ownership |
2021-02-04 5:22 pm |
N/A 2029-09-06 |
Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer |
0 | $0 | 1,069,756 (Direct) |
View |